B. Castagneto

1.0k total citations
33 papers, 735 citations indexed

About

B. Castagneto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Neurology. According to data from OpenAlex, B. Castagneto has authored 33 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 4 papers in Neurology. Recurrent topics in B. Castagneto's work include Occupational and environmental lung diseases (20 papers), Pleural and Pulmonary Diseases (13 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). B. Castagneto is often cited by papers focused on Occupational and environmental lung diseases (20 papers), Pleural and Pulmonary Diseases (13 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). B. Castagneto collaborates with scholars based in Italy, United Kingdom and United States. B. Castagneto's co-authors include Mario Botta, Andrea Ardizzoni, Silvia Zai, Manlio Mencoboni, Luciano Mutti, E. Piccolini, Daniela Degiovanni, Enrico Aitini, M.C. Pennucci and F Salvati and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

B. Castagneto

32 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Castagneto Italy 15 567 145 71 63 61 33 735
Yoshihiro Nakagami Japan 14 209 0.4× 148 1.0× 73 1.0× 34 0.5× 27 0.4× 51 583
P. Cathcart United Kingdom 9 241 0.4× 235 1.6× 45 0.6× 36 0.6× 7 0.1× 34 613
L. Bengt van Rijssen Netherlands 13 271 0.5× 481 3.3× 25 0.4× 22 0.3× 19 0.3× 21 594
Sudhir Isharwal United States 15 413 0.7× 103 0.7× 80 1.1× 37 0.6× 4 0.1× 37 567
Takahito Taniura Japan 12 160 0.3× 246 1.7× 30 0.4× 22 0.3× 11 0.2× 25 403
Amélie Deleporte Belgium 13 117 0.2× 277 1.9× 103 1.5× 23 0.4× 7 0.1× 32 486
Keigo Komine Japan 14 151 0.3× 295 2.0× 15 0.2× 48 0.8× 11 0.2× 53 585
Ping‐Tsung Chen Taiwan 14 126 0.2× 201 1.4× 16 0.2× 23 0.4× 10 0.2× 35 436
Yuan Tian China 14 328 0.6× 217 1.5× 29 0.4× 24 0.4× 5 0.1× 67 644
Vincenzo Ravo Italy 12 154 0.3× 113 0.8× 130 1.8× 10 0.2× 14 0.2× 42 413

Countries citing papers authored by B. Castagneto

Since Specialization
Citations

This map shows the geographic impact of B. Castagneto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Castagneto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Castagneto more than expected).

Fields of papers citing papers by B. Castagneto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Castagneto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Castagneto. The network helps show where B. Castagneto may publish in the future.

Co-authorship network of co-authors of B. Castagneto

This figure shows the co-authorship network connecting the top 25 collaborators of B. Castagneto. A scholar is included among the top collaborators of B. Castagneto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Castagneto. B. Castagneto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leonetti, Alessandro, Melissa Bersanelli, B. Castagneto, et al.. (2016). Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review. Clinical Genitourinary Cancer. 14(4). 277–283. 15 indexed citations
2.
Luciani, Andrea, Laura Biganzoli, Giuseppe Colloca, et al.. (2015). Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13). Journal of Geriatric Oncology. 6(4). 272–279. 62 indexed citations
3.
4.
Blayney, Jaine K., Giovanni Luca Ceresoli, B. Castagneto, et al.. (2012). Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma. European Journal of Cancer. 48(16). 2983–2992.
5.
Castagneto, B., et al.. (2010). Sustained response following sorafenib therapy in an older adult patient with advanced renal cancer on hemodialysis: a case report. Medical Oncology. 28(4). 1384–1388. 6 indexed citations
6.
Castagneto, B., P. Scullin, Michelle O’Brien, et al.. (2009). Response to chemotherapy predicts longer survival in an individual patient meta-analysis of 1205 patients with mesothelioma. Journal of Thoracic Oncology. 4(9). 1 indexed citations
7.
Taylor, Paul, B. Castagneto, G. Dark, et al.. (2008). Single-Agent Pemetrexed for Chemonaïve and Pretreated Patients with Malignant Pleural Mesothelioma: Results of an International Expanded Access Program. Journal of Thoracic Oncology. 3(7). 764–771. 39 indexed citations
8.
Ceresoli, Giovanni Luca, B. Castagneto, Paolo Andrea Zucali, et al.. (2008). Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials. British Journal of Cancer. 99(1). 51–56. 78 indexed citations
9.
Castagneto, B., Mario Botta, Enrico Aitini, et al.. (2007). Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM). Annals of Oncology. 19(2). 370–373. 102 indexed citations
10.
11.
Ceresoli, Giovanni Luca, B. Castagneto, Francesco Facciolo, et al.. (2006). Malignant pleural mesothelioma. Annals of Oncology. 17. ii13–ii16. 19 indexed citations
12.
Castagneto, B., et al.. (2005). Cisplatin and Gemcitabine in Malignant Pleural Mesothelioma: A Phase II Study. American Journal of Clinical Oncology. 28(3). 223–226. 44 indexed citations
13.
Mastro, Lucia Del, Paolo Bruzzi, Guido Nicolò, et al.. (2005). HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients. British Journal of Cancer. 93(1). 7–14. 28 indexed citations
14.
15.
Castagneto, B., Silvia Zai, Luciano Mutti, et al.. (2001). Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion. Lung Cancer. 31(2-3). 303–310. 67 indexed citations
16.
Alabiso, Oscar, B. Castagneto, A. Mancini, et al.. (2001). Limits of aortic stop flow infusion chemotherapy in the treatment of advanced cancer.. PubMed. 43(4). 243–8. 3 indexed citations
17.
Orengo, Anna Maria, Antonio Domenico Procopio, Alessandra de Cupis, et al.. (1999). Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis. European Respiratory Journal. 13(3). 527–534. 55 indexed citations
18.
Salvio, Michela Di, B. Castagneto, Michele Carbone, et al.. (1998). Recurrent chromosome 6 abnormalities in malignant mesothelioma.. PubMed. 53(2). 228–35. 4 indexed citations
19.
Ardizzoni, Andrea, M.C. Pennucci, B. Castagneto, et al.. (1994). Recombinant Interferon Alpha-2b in the Treatment of Diffuse Malignant Pleural Mesothelioma. American Journal of Clinical Oncology. 17(1). 80–82. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshihiro Nakagami Breakdown of academic impact, for papers by P. Cathcart Breakdown of academic impact, for papers by L. Bengt van Rijssen Breakdown of academic impact, for papers by Sudhir Isharwal Breakdown of academic impact, for papers by Takahito Taniura Breakdown of academic impact, for papers by Amélie Deleporte Breakdown of academic impact, for papers by Keigo Komine Breakdown of academic impact, for papers by Ping‐Tsung Chen Breakdown of academic impact, for papers by Yuan Tian Breakdown of academic impact, for papers by Vincenzo Ravo
Rankless by CCL
2026